Why the study?
Does sulfinpyrazone prevent sudden death during the first six months after myocardial infarction?
Does sulfinpyrazone prevent sudden death during the first six months after myocardial infarction?
No takes yet. Share an insight, caveat, or question.
The FDA identified significant methodological problems with the Anturane Reinfarction Trial, leading to the rejection of the claim that sulfinpyrazone prevents sudden death post-MI.
Temple et al. (1980) studied this question.